124.67
price up icon0.19%   0.24
after-market Dopo l'orario di chiusura: 123.74 -0.93 -0.75%
loading
Precedente Chiudi:
$124.43
Aprire:
$125.14
Volume 24 ore:
4.86M
Relative Volume:
0.85
Capitalizzazione di mercato:
$216.98B
Reddito:
$43.84B
Utile/perdita netta:
$13.94B
Rapporto P/E:
15.59
EPS:
7.9979
Flusso di cassa netto:
$6.78B
1 W Prestazione:
-1.32%
1M Prestazione:
-6.34%
6M Prestazione:
-4.47%
1 anno Prestazione:
+8.93%
Intervallo 1D:
Value
$124.33
$126.43
Intervallo di 1 settimana:
Value
$124.12
$128.45
Portata 52W:
Value
$110.86
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Nome
Abbott Laboratories
Name
Telefono
(224) 667-6100
Name
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Dipendente
114,000
Name
Cinguettio
@AbbottNews
Name
Prossima data di guadagno
2025-10-15
Name
Ultimi documenti SEC
Name
ABT's Discussions on Twitter

Confronta ABT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
ABT
Abbott Laboratories
124.67 216.57B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
100.57 148.62B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
368.98 141.30B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
90.97 117.65B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
83.48 48.55B 5.69B 1.41B 577.90M 6.9828

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-10 Iniziato The Benchmark Company Buy
2025-07-18 Aggiornamento Jefferies Hold → Buy
2025-06-16 Iniziato Leerink Partners Market Perform
2024-10-08 Iniziato Oppenheimer Outperform
2024-09-19 Iniziato Piper Sandler Overweight
2024-07-30 Downgrade Edward Jones Buy → Hold
2024-05-30 Iniziato Goldman Buy
2023-07-21 Aggiornamento Wolfe Research Underperform → Peer Perform
2023-05-30 Downgrade Morgan Stanley Overweight → Equal-Weight
2023-04-20 Reiterato Barclays Overweight
2023-04-20 Reiterato Bernstein Outperform
2023-04-20 Reiterato JP Morgan Overweight
2023-04-20 Reiterato Raymond James Outperform
2023-04-20 Reiterato UBS Buy
2023-04-20 Reiterato Wolfe Research Underperform
2023-03-29 Iniziato UBS Buy
2022-10-26 Iniziato Mizuho Neutral
2022-10-18 Iniziato Barclays Overweight
2022-10-12 Iniziato Jefferies Hold
2022-07-06 Iniziato Wolfe Research Underperform
2022-03-02 Ripresa BofA Securities Buy
2022-01-27 Reiterato Credit Suisse Outperform
2022-01-27 Reiterato Morgan Stanley Overweight
2022-01-27 Reiterato Raymond James Outperform
2022-01-27 Reiterato UBS Buy
2021-12-10 Iniziato RBC Capital Mkts Outperform
2021-10-27 Aggiornamento Atlantic Equities Neutral → Overweight
2021-10-14 Iniziato Redburn Neutral
2021-05-25 Iniziato Barclays Overweight
2021-04-15 Iniziato Atlantic Equities Neutral
2021-01-28 Aggiornamento BTIG Research Neutral → Buy
2020-09-11 Iniziato Wolfe Research Outperform
2020-06-01 Downgrade Goldman Neutral → Sell
2020-03-05 Iniziato Citigroup Buy
2020-02-13 Iniziato Goldman Neutral
2020-02-06 Ripresa BTIG Research Neutral
2020-01-02 Downgrade Guggenheim Buy → Neutral
2019-06-13 Reiterato BofA/Merrill Buy
2019-02-07 Reiterato BofA/Merrill Buy
2019-01-02 Downgrade Citigroup Neutral → Sell
2018-11-30 Aggiornamento Goldman Neutral → Buy
2018-10-16 Iniziato Barclays Overweight
2018-06-27 Iniziato Bernstein Outperform
2018-01-30 Reiterato Citigroup Neutral
2018-01-25 Reiterato Stifel Buy
2018-01-25 Aggiornamento William Blair Mkt Perform → Outperform
2018-01-03 Iniziato Evercore ISI Outperform
2018-01-02 Aggiornamento JP Morgan Neutral → Overweight
2018-01-02 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2017-10-19 Reiterato RBC Capital Mkts Outperform
2017-10-19 Reiterato Stifel Buy
Mostra tutto

Abbott Laboratories Borsa (ABT) Ultime notizie

pulisher
01:00 AM

Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsight - GlobeNewswire Inc.

01:00 AM
pulisher
07:10 AM

Daymark Wealth Partners LLC Boosts Stock Holdings in Abbott Laboratories $ABT - MarketBeat

07:10 AM
pulisher
07:09 AM

The Zacks Analyst Blog Highlights International Business Machines, Micron and Abbott - sharewise.com

07:09 AM
pulisher
06:42 AM

Analyst IMS Investment Management Services Ltd. Decreases Stake in Abbott Laboratories $ABT - MarketBeat

06:42 AM
pulisher
06:34 AM

Whalen Wealth Management Inc. Purchases New Position in Abbott Laboratories $ABT - MarketBeat

06:34 AM
pulisher
06:12 AM

Jennison Associates LLC Grows Stock Position in Abbott Laboratories $ABT - MarketBeat

06:12 AM
pulisher
Oct 29, 2025

Patient sues Abbott after early heart valve replacement - Cardiovascular Business

Oct 29, 2025
pulisher
Oct 29, 2025

Top Stock Reports for IBM, Micron & Abbott - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Abbott Trifecta Heart Valve Lawsuit Filed Over Device Failure, Removal - AboutLawsuits.com

Oct 29, 2025
pulisher
Oct 29, 2025

Is Abbott Laboratories stock a buy in volatile markets2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Mizuho Markets Americas LLC Sells 8,006 Shares of Abbott Laboratories $ABT - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Barclays Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $162 - 富途牛牛

Oct 29, 2025
pulisher
Oct 28, 2025

Abbott Laboratories (ABT): Evaluating Its Valuation Following Recent Share Price Pullback - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

How Abbott Laboratories stock reacts to inflationary pressuresWeekly Risk Report & AI Forecasted Stock Moves - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Data supports Abbott Tendyne mitral valve replacement - MassDevice

Oct 28, 2025
pulisher
Oct 28, 2025

Is Abbott Laboratories stock a good choice for value investors2025 Geopolitical Influence & AI Forecasted Stock Moves - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Technical signs of recovery in Abbott LaboratoriesMarket Volume Summary & Target Return Focused Stock Picks - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

What makes Abbott Laboratories stock attractive to growth fundsM&A Rumor & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Will Abbott Laboratories (ABL) stock maintain strong growth2025 Market Overview & Community Consensus Stock Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories, facing hundreds of lawsuits over safety of formula for premature babies, notches a win in federal court - Slipcase

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott’s New Study on Dydrogesterone: A Potential Game-Changer for Endometriosis Pain - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Is Abbott Laboratories (Common Stock) (ABL0) stock a buy for dividend portfoliosJuly 2025 Price Swings & Precise Buy Zone Identification - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories wins Illinois court case on NEC baby formula claims - Global Food Industry News

Oct 27, 2025
pulisher
Oct 27, 2025

Using R and stats models for Abbott Laboratories forecastingWeekly Market Summary & Real-Time Volume Triggers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories $ABT Shares Sold by Curat Global LLC - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Ashton Thomas Private Wealth LLC Raises Stake in Abbott Laboratories $ABT - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

What is the fair value estimate for Abbott Laboratories (ABL) stock in 20252025 Institutional Moves & Short-Term Trading Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will a bounce in Abbott Laboratories offer an exitSwing Trade & High Conviction Investment Ideas - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Abbott Laboratories (ABT) Surged Ahead of the Market in 2025 with Steady Earnings Momentum - MSN

Oct 26, 2025
pulisher
Oct 24, 2025

Abbott Laboratories wins lawsuit over safety of baby formula - Chicago Tribune

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether as Judge Rules Human-Milk Alternative ‘Unfeasible’ - USA Herald

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether In Cow Milk Baby Formula MDL - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott wins third of four 'bellwether' infant formula lawsuits - Crain's Chicago Business

Oct 24, 2025
pulisher
Oct 24, 2025

TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $145 - 富途牛牛

Oct 24, 2025
pulisher
Oct 24, 2025

Protein Bar Market Size, Share, and Growth 2025-2035 | Abbott - openPR.com

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Can't Expand Glucose Monitor Sales Ban At UPC - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

Meet RFK’s Corporate Underlings - The American Prospect

Oct 24, 2025
pulisher
Oct 23, 2025

Is Abbott Laboratories stock dividend growth reliableJuly 2025 Catalysts & Smart Swing Trading Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How Abbott’s Innovative Partnerships Are Shaping Its 2025 Valuation Amid 12.8% YTD Gain - simplywall.st

Oct 23, 2025
pulisher
Oct 23, 2025

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall - GlobeNewswire

Oct 23, 2025
pulisher
Oct 23, 2025

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question - The Globe and Mail

Oct 23, 2025
pulisher
Oct 22, 2025

Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

Dechert Advises the Shareholders of LARALAB GmbH on ... - Dechert

Oct 22, 2025
pulisher
Oct 22, 2025

A Look Into Abbott Laboratories Inc's Price Over Earnings - Sahm

Oct 22, 2025
pulisher
Oct 22, 2025

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

How Abbott Laboratories stock compares to growth peersMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Abbott Laboratories (Common Stock) (ABL0) stock sustain margin levelsGap Down & Entry and Exit Point Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories (ABL) stock cheap by valuation metricsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories showing signs of accumulationMarket Movement Recap & Expert Approved Momentum Ideas - newser.com

Oct 21, 2025

Abbott Laboratories Azioni (ABT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices BSX
$100.57
price up icon 0.27%
medical_devices SYK
$368.98
price down icon 0.17%
medical_devices MDT
$90.97
price down icon 0.83%
medical_devices EW
$83.48
price up icon 0.96%
$75.00
price down icon 3.08%
Capitalizzazione:     |  Volume (24 ore):